184 related articles for article (PubMed ID: 19177587)
1. Hepatitis B e antigen-negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL.
Dai CY; Chuang WL; Huang JF; Yu ML
Hepatology; 2009 Feb; 49(2):704-5; author reply 705-6. PubMed ID: 19177587
[No Abstract] [Full Text] [Related]
2. A call for attention and trials on hepatitis B e antigen-negative, alanine aminotransferase-normal chronic hepatitis B virus infection.
Zhao H; Miao R
Hepatology; 2009 Aug; 50(2):658; author reply 658-9. PubMed ID: 19585650
[No Abstract] [Full Text] [Related]
3. [Antiviral effects of entecavir in patients with hepatitis B virus-related cirrhosis].
Xu Y; Wang JB; Xu J; Jiao J; Zhang YG; Ji SW; Zhao P; Guo HH; Li Y; Zhou CY
Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):109-12. PubMed ID: 20196949
[TBL] [Abstract][Full Text] [Related]
4. [Association between IgG antibody against the C-terminal region of the preS1 protein of hepatitis B virus and the early response to interferon therapy in chronic hepatitis B].
Xia GM; Zhang ZH; Wei SF; Gao YF; Zhang TT; Zhang L; Li X
Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):1-4. PubMed ID: 20128959
[TBL] [Abstract][Full Text] [Related]
5. Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels.
Tseng TC; Liu CJ; Wang CC; Chen PJ; Lai MY; Chen DS; Kao JH
Antivir Ther; 2009; 14(2):203-10. PubMed ID: 19430095
[TBL] [Abstract][Full Text] [Related]
6. [Dynamics of hepatitis B virus covalently closed circular DNA after serum virology response].
Li FF; Ren WH; Ding GH; Shi J; Han GQ
Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):167-70. PubMed ID: 19335976
[TBL] [Abstract][Full Text] [Related]
7. Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapy.
Yuen MF; Fung J; Seto WK; Wong DK; Yuen JC; Lai CL
Antivir Ther; 2009; 14(5):679-85. PubMed ID: 19704171
[TBL] [Abstract][Full Text] [Related]
8. A 7-year study of lamivudine therapy for hepatitis B virus e antigen-positive chronic hepatitis B patients in China.
Yao GB; Zhu M; Cui ZY; Wang BE; Yao JL; Zeng MD
J Dig Dis; 2009 May; 10(2):131-7. PubMed ID: 19426396
[TBL] [Abstract][Full Text] [Related]
9. To stop or not to stop: the quest for long-term viral suppression.
Fung J; Lai CL; Yuen MF
J Gastroenterol Hepatol; 2011 Mar; 26(3):420-2. PubMed ID: 21332537
[No Abstract] [Full Text] [Related]
10. The Use of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase.
Lo GH
Gastroenterology; 2014 Sep; 147(3):718-9. PubMed ID: 25075941
[No Abstract] [Full Text] [Related]
11. [Effect of interferon neutralization antibody in the treatment of chronic hepatitis B with interferon].
CHEN XR; WANG HL; XUAN MX; MAO XG; SUN JG; WAN BM
Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):385-6. PubMed ID: 19497208
[No Abstract] [Full Text] [Related]
12. Chronic hepatitis B in children and adolescents.
Paganelli M; Stephenne X; Sokal EM
J Hepatol; 2012 Oct; 57(4):885-96. PubMed ID: 22634122
[No Abstract] [Full Text] [Related]
13. [Predictors for virologic response in management of chronic hepatitis B].
Lee JM; Ahn SH
Korean J Hepatol; 2010 Mar; 16(1):1-4. PubMed ID: 20375637
[No Abstract] [Full Text] [Related]
14. Does hepatitis B surface antigen kinetics, including both decline and reaching a threshold, improve prediction of response?
Wiegand J; Patel K; Tillmann HL
Hepatology; 2009 Oct; 50(4):1314; author reply 1314. PubMed ID: 19676132
[No Abstract] [Full Text] [Related]
15. Should antiviral treatment be extended to patients with chronic hepatitis B and mildly elevated alanine aminotransferase?
Lok AS
Hepatology; 2010 Apr; 51(4):1107-9. PubMed ID: 20162620
[No Abstract] [Full Text] [Related]
16. [Are phyllanthus species effective in hepatitis B?].
Rakowitz B
Dtsch Med Wochenschr; 2011 Jul; 136(28-29):1460. PubMed ID: 21732258
[No Abstract] [Full Text] [Related]
17. EASL clinical practice guidelines on the management of chronic hepatitis B: the need for liver biopsy.
Papatheodoridis GV; Manolakopoulos S
J Hepatol; 2009 Jul; 51(1):226-7. PubMed ID: 19410321
[No Abstract] [Full Text] [Related]
18. Assessment of clinical utility of low and high normal alanine aminotransferase values in patients with chronic hepatitis B virus infection in Bangladesh.
Al-Mahtab M; Rahman S; Akbar SM; Kamal M; Khan MS
Digestion; 2011; 83(1-2):60-4. PubMed ID: 20975272
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus-related membranous nephropathy treated with entecavir.
Ikee R; Ishioka K; Oka M; Maesato K; Moriya H; Hidaka S; Ohtake T; Kobayashi S
Nephrology (Carlton); 2010 Mar; 15(2):266. PubMed ID: 20470290
[No Abstract] [Full Text] [Related]
20. Influence of hepatitis B virus (HBV) genotype on the clinical course of disease in patients coinfected with HBV and hepatitis delta virus.
Kiesslich D; Crispim MA; Santos C; Ferreira Fde L; Fraiji NA; Komninakis SV; Diaz RS
J Infect Dis; 2009 Jun; 199(11):1608-11. PubMed ID: 19388852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
